Pulike Biological Engineering, Inc. (SHA:603566)

China · Delayed Price · Currency is CNY

10.74

-0.19 (-1.74%)

Jun 2, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pig Vaccine	263.11M	-
Poultry Vaccines and Antibodies	485.23M	-
Vaccines for Ruminants	6.38M	-
Pets	16.09M	-
Chemical	253.71M	-
Functional Health Products, Etc.	24.65M	-
Technology Licensing or Transfer Income	27.78M	-
Total	1.08B	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Northeast China	129.88M	-						-	-	-
North China	95.20M	-						-	-	-
East China	364.75M	-						-	-	-
South China	126.31M	-						-	-	-
Central China	205.37M	-						-	-	-
Northwest China	34.53M	-						-	-	-
Southwest China	95.93M	-						-	-	-
Overseas	24.97M	-						-	-	-
China	-	-						608.06M	529.90M	583.10M
China Growth	-	-						14.75%	-9.12%	21.95%
Total	1.08B	-						608.06M	529.90M	583.10M
Total Growth	-	-						14.75%	-9.12%	21.95%

Source: S&P Global Market Intelligence.